VL30 retrotransposition is associated with induced EMT, CSC generation and tumorigenesis in HC11 mouse mammary stem‑like epithelial cells

Thrasyvoulou,Soteroula; Vartholomatos,Georgios; Markopoulos,Georgios; Noutsopoulos,Dimitrios; Mantziou,Stefania; Gkartziou,Foteini; Papageorgis,Panagiotis; Charchanti,Antonia; Kouklis,Panos; Constantinou,Andreas I.; Tzavaras,Theodore

doi:10.3892/or.2020.7596

VL30 retrotransposition is associated with induced EMT, CSC generation and tumorigenesis in HC11 mouse mammary stem‑like epithelial cells

Authors:
- Soteroula Thrasyvoulou
- Georgios Vartholomatos
- Georgios Markopoulos
- Dimitrios Noutsopoulos
- Stefania Mantziou
- Foteini Gkartziou
- Panagiotis Papageorgis
- Antonia Charchanti
- Panos Kouklis
- Andreas I. Constantinou
- Theodore Tzavaras
View Affiliations

Affiliations: Laboratory of General Biology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece, Laboratory of Hematology, Unit of Molecular Biology, University Hospital of Ioannina, 45110 Ioannina, Greece, Biological Sciences Program, Department of Life Sciences, School of Sciences, European University Cyprus, 2404 Nicosia, Cyprus, Laboratory of Anatomy‑Histology‑Embryology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece, Department of Biological Sciences, Faculty of Pure and Applied Sciences, University of Cyprus, 1678 Nicosia, Cyprus
Published online on: April 28, 2020 https://doi.org/10.3892/or.2020.7596
Pages: 126-138

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Retrotransposons copy their sequences via an RNA intermediate, followed by reverse transcription into cDNA and random insertion, into a new genomic locus. New retrotransposon copies may lead to cell transformation and/or tumorigenesis through insertional mutagenesis. Methylation is a major defense mechanism against retrotransposon RNA expression and retrotransposition in differentiated cells, whereas stem cells are relatively hypo‑methylated. Epithelial‑to‑mesenchymal transition (EMT), which transforms normal epithelial cells into mesenchymal‑like cells, also contributes to tumor progression and tumor metastasis. Cancer stem cells (CSCs), a fraction of undifferentiated tumor‑initiating cancer cells, are reciprocally related to EMT. In the present study, the outcome of long terminal repeat (LTR)‑Viral‑Like 30 (VL30) retrotransposition was examined in mouse mammary stem‑like/progenitor HC11 epithelial cells. The transfection of HC11 cells with a VL30 retrotransposon, engineered with an EGFP‑based retrotransposition cassette, elicited a higher retrotransposition frequency in comparison to differentiated J3B1A and C127 mouse mammary cells. Fluorescence microscopy and PCR analysis confirmed the specificity of retrotransposition events. The differentiated retrotransposition‑positive cells retained their epithelial morphology, while the respective HC11 cells acquired mesenchymal features associated with the loss of E‑cadherin, the induction of N‑cadherin, and fibronectin and vimentin protein expression, as well as an increased transforming growth factor (TGF)‑β1, Slug, Snail‑1 and Twist mRNA expression. In addition, they were characterized by cell proliferation in low serum, and the acquisition of CSC‑like properties indicated by mammosphere formation under anchorage‑independent conditions. Mammospheres exhibited an increased Nanog and Oct4 mRNA expression and a CD44+/CD24‑/low antigenic phenotype, as well as self‑renewal and differentiation capacity, forming mammary acini‑like structures. DNA sequencing analysis of retrotransposition‑positive HC11 cells revealed retrotransposed VL30 copies integrated at the vicinity of EMT‑, cancer type‑ and breast cancer‑related genes. The inoculation of these cells into Balb/c mice produced cytokeratin‑positive tumors containing pancytokeratin‑positive cells, indicative of cell invasion features. On the whole, the findings of the present study demonstrate, for the first time, to the best of our knowledge, that stem‑like epithelial HC11 cells are amenable to VL30 retrotransposition associated with the induction of EMT and CSC generation, leading to tumorigenesis.

View Figures

View References

1	Markopoulos G, Noutsopoulos D, Mantziou S, Gerogiannis D, Thrasyvoulou S, Vartholomatos G, Kolettas E and Tzavaras T: Genomic analysis of mouse VL30 retrotransposons. Mob DNA. 7:102016. View Article : Google Scholar : PubMed/NCBI
2	French NS and Norton JD: Structure and functional properties of mouse VL30 retrotransposons. Biochim Biophys Acta. 1352:33–47. 1997. View Article : Google Scholar : PubMed/NCBI
3	Noutsopoulos D, Markopoulos G, Koliou M, Dova L, Vartholomatos G, Kolettas E and Tzavaras T: Vanadium induces VL30 retrotransposition at an unusually high level: A possible carcinogenesis mechanism. J Mol Biol. 374:80–90. 2007. View Article : Google Scholar : PubMed/NCBI
4	Tzavaras T, Eftaxia S, Tavoulari S, Hatzi P and Angelidis C: Factors influencing the expression of endogenous reverse transcriptases and viral-like 30 elements in mouse NIH3T3 cells. Int J Oncol. 23:1237–1243. 2003.PubMed/NCBI
5	Tzavaras T, Kalogera C, Eftaxia S, Saragosti S and Pagoulatos GN: Clone-specific high-frequency retrotransposition of a recombinant virus containing a VL30 promoter in SV40-transformed NIH3T3 cells. Biochim Biophys Acta. 1442:186–198. 1998. View Article : Google Scholar : PubMed/NCBI
6	Song X, Sun Y and Garen A: Roles of PSF protein and VL30 RNA in reversible gene regulation. Proc Natl Acad Sci USA. 102:12189–12193. 2005. View Article : Google Scholar : PubMed/NCBI
7	Wang G, Cui Y, Zhang G, Garen A and Song X: Regulation of proto-oncogene transcription, cell proliferation, and tumorigenesis in mice by PSF protein and a VL30 noncoding RNA. Proc Natl Acad Sci USA. 106:16794–16798. 2009. View Article : Google Scholar : PubMed/NCBI
8	Song X, Sui A and Garen A: Binding of mouse VL30 retrotransposon RNA to PSF protein induces genes repressed by PSF: Effects on steroidogenesis and oncogenesis. Proc Natl Acad Sci USA. 101:621–626. 2004. View Article : Google Scholar : PubMed/NCBI
9	Costain WJ, Rasquinha I, Graber T, Luebbert C, Preston E, Slinn J, Xie X and MacManus JP: Cerebral ischemia induces neuronal expression of novel VL30 mouse retrotransposons bound to polyribosomes. Brain Res. 1094:24–37. 2006. View Article : Google Scholar : PubMed/NCBI
10	Scolnick EM, Vass WC, Howk RS and Duesberg PH: Defective retrovirus-like 30S RNA species of rat and mouse cells are infectious if packaged by type C helper virus. J Virol. 29:964–972. 1979. View Article : Google Scholar : PubMed/NCBI
11	Song X, Wang B, Bromberg M, Hu Z, Konigsberg W and Garen A: Retroviral-mediated transmission of a mouse VL30 RNA to human melanoma cells promotes metastasis in an immunodeficient mouse model. Proc Natl Acad Sci USA. 99:6269–6273. 2002. View Article : Google Scholar : PubMed/NCBI
12	Noutsopoulos D, Vartholomatos G, Kolaitis N and Tzavaras T: SV40 large T antigen up-regulates the retrotransposition frequency of viral-like 30 elements. J Mol Biol. 361:450–461. 2006. View Article : Google Scholar : PubMed/NCBI
13	Noutsopoulos D, Markopoulos G, Vartholomatos G, Kolettas E, Kolaitis N and Tzavaras T: VL30 retrotransposition signals activation of a caspase-independent and p53-dependent death pathway associated with mitochondrial and lysosomal damage. Cell Res. 20:553–562. 2010. View Article : Google Scholar : PubMed/NCBI
14	Boeke JD, Garfinkel DJ, Styles CA and Fink GR: Ty elements transpose through an RNA intermediate. Cell. 40:491–500. 1985. View Article : Google Scholar : PubMed/NCBI
15	Georgiou I, Noutsopoulos D, Dimitriadou E, Markopoulos G, Apergi A, Lazaros L, Vaxevanoglou T, Pantos K, Syrrou M and Tzavaras T: Retrotransposon RNA expression and evidence for retrotransposition events in human oocytes. Hum Mol Genet. 18:1221–1228. 2009. View Article : Google Scholar : PubMed/NCBI
16	Goodier JL and Kazazian HH Jr: Retrotransposons revisited: The restraint and rehabilitation of parasites. Cell. 135:23–35. 2008. View Article : Google Scholar : PubMed/NCBI
17	Guarino M, Rubino B and Ballabio G: The role of epithelial-mesenchymal transition in cancer pathology. Pathology. 39:305–318. 2007. View Article : Google Scholar : PubMed/NCBI
18	Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED and Thompson EW: Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol. 213:374–383. 2007. View Article : Google Scholar : PubMed/NCBI
19	Papageorgis P, Lambert AW, Ozturk S, Gao F, Pan H, Manne U, Alekseyev YO, Thiagalingam A, Abdolmaleky HM, Lenburg M and Thiagalingam S: Smad signaling is required to maintain epigenetic silencing during breast cancer progression. Cancer Res. 70:968–978. 2010. View Article : Google Scholar : PubMed/NCBI
20	Barrallo-Gimeno A and Nieto MA: The Snail genes as inducers of cell movement and survival: Implications in development and cancer. Development. 132:3151–3161. 2005. View Article : Google Scholar : PubMed/NCBI
21	Bhowmick NA, Neilson EG and Moses HL: Stromal fibroblasts in cancer initiation and progression. Nature. 432:332–337. 2004. View Article : Google Scholar : PubMed/NCBI
22	Moreno-Bueno G, Portillo F and Cano A: Transcriptional regulation of cell polarity in EMT and cancer. Oncogene. 27:6958–6969. 2008. View Article : Google Scholar : PubMed/NCBI
23	Hayashida T, Jinno H, Kitagawa Y and Kitajima M: Cooperation of cancer stem cell properties and epithelial-mesenchymal transition in the establishment of breast cancer metastasis. J Oncol. 2011:5914272011. View Article : Google Scholar : PubMed/NCBI
24	Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
25	Daniel CW, Young LJ, Medina D and DeOme KB: The influence of mammogenic hormones on serially transplanted mouse mammary gland. Exp Gerontol. 6:95–101. 1971. View Article : Google Scholar : PubMed/NCBI
26	Smith GH and Medina D: Re-evaluation of mammary stem cell biology based on in vivo transplantation. Breast Cancer Res. 10:2032008. View Article : Google Scholar : PubMed/NCBI
27	Van Keymeulen A, Rocha AS, Ousset M, Beck B, Bouvencourt G, Rock J, Sharma N, Dekoninck S and Blanpain C: Distinct stem cells contribute to mammary gland development and maintenance. Nature. 479:189–193. 2011. View Article : Google Scholar : PubMed/NCBI
28	Holland JD, Klaus A, Garratt AN and Birchmeier W: Wnt signaling in stem and cancer stem cells. Curr Opin Cell Biol. 25:254–264. 2013. View Article : Google Scholar : PubMed/NCBI
29	Zhou W, Wang G and Guo S: Regulation of angiogenesis via Notch signaling in breast cancer and cancer stem cells. Biochim Biophys Acta. 1836:304–320. 2013.PubMed/NCBI
30	Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ and Wicha MS: In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17:1253–1270. 2003. View Article : Google Scholar : PubMed/NCBI
31	Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
32	Goodier JL: Restricting retrotransposons: A review. Mob DNA. 7:162016. View Article : Google Scholar : PubMed/NCBI
33	Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein BE and Jaenisch R: In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature. 448:318–324. 2007. View Article : Google Scholar : PubMed/NCBI
34	Ball RK, Friis RR, Schoenenberger CA, Doppler W and Groner B: Prolactin regulation of beta-casein gene expression and of a cytosolic 120-kd protein in a cloned mouse mammary epithelial cell line. EMBO J. 7:2089–2095. 1988. View Article : Google Scholar : PubMed/NCBI
35	Humphreys RC and Rosen JM: Stably transfected HC11 cells provide an in vitro and in vivo model system for studying Wnt gene function. Cell Growth Differ. 8:839–849. 1997.PubMed/NCBI
36	Williams C, Helguero L, Edvardsson K, Haldosen LA and Gustafsson JA: Gene expression in murine mammary epithelial stem cell-like cells shows similarities to human breast cancer gene expression. Breast Cancer Res. 11:R262009. View Article : Google Scholar : PubMed/NCBI
37	Montesano R, Soriano JV, Fialka I and Orci L: Isolation of EpH4 mammary epithelial cell subpopulations which differ in their morphogenetic properties. In Vitro Cell Dev Biol Anim. 34:468–477. 1998. View Article : Google Scholar : PubMed/NCBI
38	Ostertag EM, Prak ET, DeBerardinis RJ, Moran JV and Kazazian HH Jr: Determination of L1 retrotransposition kinetics in cultured cells. Nucleic Acids Res. 28:1418–1423. 2000. View Article : Google Scholar : PubMed/NCBI
39	Puschendorf M, Stein P, Oakeley EJ, Schultz RM, Peters AH and Svoboda P: Abundant transcripts from retrotransposons are unstable in fully grown mouse oocytes. Biochem Biophys Res Commun. 347:36–43. 2006. View Article : Google Scholar : PubMed/NCBI
40	Xiong Y and Eickbush TH: Origin and evolution of retroelements based upon their reverse transcriptase sequences. EMBO J. 9:3353–3362. 1990. View Article : Google Scholar : PubMed/NCBI
41	Langmead B and Salzberg SL: Fast gapped-read alignment with Bowtie 2. Nat Methods. 9:357–359. 2012. View Article : Google Scholar : PubMed/NCBI
42	M M: Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 17:10–12. 2011. View Article : Google Scholar
43	Voulgari A and Pintzas A: Epithelial-mesenchymal transition in cancer metastasis: Mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta. 1796:75–90. 2009.PubMed/NCBI
44	Jen J and Wang YC: Zinc finger proteins in cancer progression. J Biomed Sci. 23:532016. View Article : Google Scholar : PubMed/NCBI
45	Davis NM, Sokolosky M, Stadelman K, Abrams SL, Libra M, Candido S, Nicoletti F, Polesel J, Maestro R, D'Assoro A, et al: Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: Possibilities for therapeutic intervention. Oncotarget. 5:4603–4650. 2014. View Article : Google Scholar : PubMed/NCBI
46	Li X, Yang Q, Yu H, Wu L, Zhao Y, Zhang C, Yue X, Liu Z, Wu H, Haffty BG, et al: LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway. Oncotarget. 5:788–801. 2014. View Article : Google Scholar : PubMed/NCBI
47	Barak V, Goike H, Panaretakis KW and Einarsson R: Clinical utility of cytokeratins as tumor markers. Clin Biochem. 37:529–540. 2004. View Article : Google Scholar : PubMed/NCBI
48	Merlo GR, Venesio T, Taverna D, Marte BM, Callahan R and Hynes NE: Growth suppression of normal mammary epithelial cells by wild-type p53. Oncogene. 9:443–453. 1994.PubMed/NCBI
49	Hancks DC and Kazazian HH Jr: Active human retrotransposons: Variation and disease. Curr Opin Genet Dev. 22:191–203. 2012. View Article : Google Scholar : PubMed/NCBI
50	Yoder JA, Walsh CP and Bestor TH: Cytosine methylation and the ecology of intragenomic parasites. Trends Genet. 13:335–340. 1997. View Article : Google Scholar : PubMed/NCBI
51	Konisti S, Mantziou S, Markopoulos G, Thrasyvoulou S, Vartholomatos G, Sainis I, Kolettas E, Noutsopoulos D and Tzavaras T: H2O2 signals via iron induction of VL30 retrotransposition correlated with cytotoxicity. Free Radic Biol Med. 52:2072–2081. 2012. View Article : Google Scholar : PubMed/NCBI
52	Markopoulos G, Noutsopoulos D, Mantziou S, Vartholomatos G, Monokrousos N, Angelidis C and Tzavaras T: Arsenic induces VL30 retrotransposition: The involvement of oxidative stress and heat-shock protein 70. Toxicol Sci. 134:312–322. 2013. View Article : Google Scholar : PubMed/NCBI
53	Deugnier MA, Faraldo MM, Teuliere J, Thiery JP, Medina D and Glukhova MA: Isolation of mouse mammary epithelial progenitor cells with basal characteristics from the Comma-Dbeta cell line. Dev Biol. 293:414–425. 2006. View Article : Google Scholar : PubMed/NCBI
54	Bloushtain-Qimron N, Yao J, Snyder EL, Shipitsin M, Campbell LL, Mani SA, Hu M, Chen H, Ustyansky V, Antosiewicz JE, et al: Cell type-specific DNA methylation patterns in the human breast. Proc Natl Acad Sci USA. 105:14076–14081. 2008. View Article : Google Scholar : PubMed/NCBI
55	Heidmann T, Heidmann O and Nicolas JF: An indicator gene to demonstrate intracellular transposition of defective retroviruses. Proc Natl Acad Sci USA. 85:2219–2223. 1988. View Article : Google Scholar : PubMed/NCBI
56	Maston GA, Evans SK and Green MR: Transcriptional regulatory elements in the human genome. Annu Rev Genomics Hum Genet. 7:29–59. 2006. View Article : Google Scholar : PubMed/NCBI
57	Lamouille S, Xu J and Derynck R: Molecular mechanisms of epithelial-mesenchymal transition. Nature reviews. Mol Cell Biol. 15:178–196. 2014.
58	Vesuna F, van Diest P, Chen JH and Raman V: Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem Biophys Res Commun. 367:235–241. 2008. View Article : Google Scholar : PubMed/NCBI
59	Moustakas A and Heldin P: TGFβ and matrix-regulated epithelial to mesenchymal transition. Biochim Biophys Acta. 1840:2621–2634. 2014. View Article : Google Scholar : PubMed/NCBI
60	Adissu HA, Asem EK and Lelievre SA: Three-dimensional cell culture to model epithelia in the female reproductive system. Reprod Sci. 14:11–19. 2007. View Article : Google Scholar : PubMed/NCBI
61	Tantin D: Oct transcription factors in development and stem cells: insights and mechanisms. Development. 140:2857–2866. 2013. View Article : Google Scholar : PubMed/NCBI
62	Fuxe J, Vincent T and Garcia de Herreros A: Transcriptional crosstalk between TGF-beta and stem cell pathways in tumor cell invasion: Role of EMT promoting Smad complexes. Cell Cycle. 9:2363–2374. 2010. View Article : Google Scholar : PubMed/NCBI
63	Duensing S and Munger K: Centrosomes, genomic instability, and cervical carcinogenesis. Crit Rev Eukaryot Gene Expr. 13:9–23. 2003. View Article : Google Scholar : PubMed/NCBI
64	Ponti D, Zaffaroni N, Capelli C and Daidone MG: Breast cancer stem cells: An overview. Eur J Cancer. 42:1219–1224. 2006. View Article : Google Scholar : PubMed/NCBI
65	Stingl J and Caldas C: Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer. 7:791–799. 2007. View Article : Google Scholar : PubMed/NCBI
66	Nishi M, Sakai Y, Akutsu H, Nagashima Y, Quinn G, Masui S, Kimura H, Perrem K, Umezawa A, Yamamoto N, et al: Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors. Oncogene. 33:643–652. 2014. View Article : Google Scholar : PubMed/NCBI